Evidence-graded · Source-cited Peer-reviewer panel · 6 clinicians
PeptideVox
Legal

Terms of Use

Last updated June 30, 2026

These Terms of Use (“Terms”) govern your access to and use of peptidevox.com, the The Evidence Brief newsletter, and related services (the “Services”), provided by PeptideVox (“we,” “us,” or “our”). By accessing or using the Services, you agree to these Terms. If you do not agree, do not use the Services.

License and acceptable use

We grant you a limited, personal, non-exclusive, non-transferable, revocable license to access and view the Services for your own non-commercial use. You agree not to:

Intellectual property

The Services and all content, design, text, graphics, logos, and trademarks are owned by or licensed to PeptideVox and are protected by intellectual-property laws. We reserve all rights not expressly granted. You may share links to our content with appropriate attribution, but you acquire no ownership or license beyond the limited rights stated here.

No professional advice

The Services provide news, commentary, and general information. They are not professional, financial, investment, legal, or other advice, and you should not rely on them as such. You are solely responsible for decisions you make based on the Services.

Third-party content and links

The Services may reference or link to third-party websites, products, and content. We do not control and are not responsible for third-party materials, and a link does not imply endorsement. Your dealings with third parties are solely between you and them.

Disclaimers

THE SERVICES ARE PROVIDED “AS IS” AND “AS AVAILABLE,” WITHOUT WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, AND NON-INFRINGEMENT. WE DO NOT WARRANT THAT THE SERVICES WILL BE UNINTERRUPTED, ERROR-FREE, OR SECURE.

Limitation of liability

TO THE MAXIMUM EXTENT PERMITTED BY LAW, PEPTIDEVOX AND ITS AFFILIATES, OFFICERS, EMPLOYEES, AND AGENTS WILL NOT BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, OR ANY LOSS OF PROFITS, DATA, OR GOODWILL, ARISING FROM OR RELATED TO YOUR USE OF THE SERVICES. OUR TOTAL LIABILITY FOR ALL CLAIMS WILL NOT EXCEED ONE HUNDRED US DOLLARS (US$100).

Indemnification

You agree to indemnify, defend, and hold harmless PeptideVox and its affiliates from any claims, damages, losses, liabilities, and expenses (including reasonable attorneys’ fees) arising out of your use of the Services or your violation of these Terms.

Changes and termination

We may modify, suspend, or discontinue the Services, or update these Terms, at any time. Changes to the Terms are effective when posted, and your continued use constitutes acceptance. We may suspend or terminate your access at our discretion, including for any violation of these Terms.

Governing law and disputes

These Terms are governed by the laws of the State of Delaware, USA, without regard to its conflict-of-laws rules. Any dispute will be resolved exclusively by binding individual arbitration, and you and PeptideVox waive any right to a jury trial or to participate in a class or representative action, to the fullest extent permitted by law. If any provision is found unenforceable, the remaining provisions remain in effect.

Contact

Questions about these Terms? Email editor@peptidevox.com.

Medical Disclaimer · Read in full

PeptideVox is an evidence reference, not medical advice. Nothing here authorizes you to acquire, possess, or self-administer any compound.

01 · Not FDA-approved

The majority of compounds documented here are not approved by the FDA for human use. Approved drugs (e.g. semaglutide, tirzepatide) are noted explicitly and require a licensed prescriber.

02 · Research chemicals

Many peptides — including BPC-157 and GHK-Cu in injectable form — are sold strictly "for research use only — not for human consumption." Purity, identity, and dosing of such products are not regulated or guaranteed.

03 · WADA-prohibited

Several compounds are banned in competitive sport under the WADA Prohibited List. Athletes risk sanction regardless of intent or formulation.

04 · Consult a clinician

Always consult a qualified, licensed healthcare professional before considering any compound. Individual risk depends on your full medical context.

This content is for informational and educational purposes only · No physician–patient relationship is created · Evidence grades reflect published data as of the stated revision and may change.